Deep Medicine Acquisition - Units (1 Ord Share Class A , 1Right) Profit Margin

As of the most recent data (June 2026), DMAQU shows a profit margin of -55.68%. That compares with -52.55% in the prior-year period — down 5.9% year over year. That is below the sector sector average of 13.78%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, DMAQU's profit margin is now -55.68% (was -52.55%) — a 5.9% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Deep Medicine Acquisition - Units (1 Ord Share Class A , 1Right) is outperforming or lagging.

The its sector sector average profit margin is about 13.78%. Deep Medicine Acquisition - Units (1 Ord Share Class A , 1Right) is at -55.68%, which is lower that average. That is roughly 504.1% below the sector mean. Use the comparison chart on this page to see how DMAQU stacks up against individual peers as well.

That compares with -52.55% in the prior-year period — down 5.9% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Deep Medicine Acquisition - Units (1 Ord Share Class A , 1Right) with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has Deep Medicine Acquisition - Units (1 Ord Share Class A , 1Right)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently -55.68%) with ownership activity and broader fundamentals.